NTHL1 and ovarian cancer: Although we excluded patients with multiple breast/ovarian cancers without polyposis from this study, routine testing since 2019 in our department did not find any such patient with biallelic NTHL1 deleterious variants, although there are cases reported in the literature presenting with bilateral breast cancer before the colorectal phenotypes (Weatherill et al., 2023).